Aspira Women's Health signs 5-year lab services pact with Mayo Clinic

Aspira Women's Health Inc.

Aspira will provide Ova1Plus and OvaWatch tests to Mayo on a non-exclusive, as-requested basis for clinical purposes.
Initial term of 5 years, automatic annual renewals; either party may terminate with 90 days' notice.
Mayo to list tests in its catalog, handle ordering, results delivery, and billing; Aspira invoices Mayo.
Fees fixed during initial term absent mutual adjustment; agreement not yet filed due to redactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.